There was a significantly higher expression of miR-92a-1-5p in samples from patients with elevated percentages of the BCR::ABL1 transcripts, compared to the healthy control group (p = 0.0220) (Figure 1), in spite of great variation among CML samples. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.